Researchers at UT Austin and UT MD Anderson say an experimental chemotherapy drug prompts cancer cells to mimic viral infections, triggering an immune response that attacks tumors and may reduce the need for higher chemo doses.
Researchers at UT Austin and UT MD Anderson say an experimental chemotherapy drug prompts cancer cells to mimic viral infections, triggering an immune response that attacks tumors and may reduce the need for higher chemo doses.